Related Experiment Video
Updated: Aug 11, 2026

Imaging of Estrogen Receptor-α in Rat Pial Arterioles using a Digital Immunofluorescent Microscope
Published on: November 29, 2011
Estrogen binding sites and estrophilin histochemistry and their correlation with oestrogen receptor biochemistry
Abstract:
Since the application of mono- and poly-clonal antibodies to the estrogen receptor protein (estrophilin) classically admitted opinions about the interactions between estrogens and their target cells have changed. Biochemical assays of ER have been shown to provide false negative results; the key-mechanism seems to be located at the nuclear level, while until now most emphasis was put on cytosolic ER. In histochemistry, apparently contradictory reports have emphasized either cytoplasmic or nuclear labelling of estrogen binding sites (EBS). A lot of supputations have tried to explain in vitro translocations from the cytoplasm to the nucleus according to the physicochemical conditions which were used. Reading of some articles gives the impression that EBS histochemistry is yet an established and reliable method; commercially available histochemical "kits" may support this false idea. Therefore it is absolutely mandatory to intend to remain cautious and critical. Stepwise our knowledge is increasing; it is absolutely clear that the problems which did rise thanks to the "contradictory" histochemical studies gave a new impetus to both biochemical and histochemical research. Immunohisto- and cyto-chemistry of EBS and estrophilin go on in parallel and in correlation with biochemistry.
Insights
Monoclonal antibodies targeting estrogen receptors (ER) have shifted understanding of estrogen interactions. Research now emphasizes nuclear ER mechanisms, challenging previous cytosolic focus and improving ER assays.
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Biology
Background:
- Estrogen receptor (estrophilin) research has evolved with antibody applications.
- Biochemical assays for ER have yielded false negatives, indicating nuclear mechanisms are key.
- Conflicting histochemical reports on estrogen binding sites (EBS) highlight cytoplasmic vs. nuclear localization.
Purpose of the Study:
- To critically evaluate the reliability of estrogen binding site (EBS) histochemistry.
- To reconcile contradictory findings in estrogen receptor (ER) localization studies.
- To emphasize the importance of nuclear ER mechanisms over cytosolic ones.
Main Methods:
- Application of monoclonal and polyclonal antibodies to estrogen receptor protein.
- Biochemical assays to assess ER activity and localization.
- Histochemical techniques for studying estrogen binding sites (EBS) in cells.
- In vitro studies to explain cytoplasmic to nuclear translocation of EBS.
Main Results:
- Antibody applications have revised understanding of estrogen-target cell interactions.
- Nuclear localization is now recognized as the primary site for ER mechanisms.
- Histochemical studies, despite contradictions, have spurred further research.
- Commercial kits may inaccurately suggest established reliability of EBS histochemistry.
Conclusions:
- A cautious and critical approach to EBS histochemistry is essential.
- Estrogen receptor research is advancing, integrating biochemical and histochemical findings.
- Nuclear ER mechanisms are crucial for understanding estrogen's role in target cells.
- Ongoing research in immuno-histo- and cyto-chemistry of EBS and estrophilin correlates with biochemical data.
Related Concept Videos
Intracellular Hormone Receptors
Internal Receptors
The Equilibrium Binding Constant and Binding Strength
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...

